论文部分内容阅读
盐酸羟二氢可待因酮( 1 4 hydroxy 7,8 dihy drocodeinone)与吗啡同为WHO推荐的治疗中、重度疼痛的阿片类药物。本药历史已很久,但并没有引起太多的注意。传统认为羟二氢可待因酮是与吗啡同样的μ受体激动剂。但1 997年发现它还可作用于κ受体。因此作为可替代吗啡的阿片类物质
Hydrocodone hydrochloride (1 4 hydroxy 7,8 dihy drocodeinone) with morphine is the WHO recommended treatment of moderate to severe pain opioids. This medicine has a long history, but did not cause too much attention. It is conventionally believed that oxycodone is the same mu receptor agonist as morphine. However, it was found in 1997 to act on the kappa receptor. So as an alternative to morphine opioids